Lobbying

Frequency Therapeutics's latest lobbying report covers Q1 2023, at $30K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.

Frequency Therapeutics

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Frequency Therapeutics lobbying by quarter
Frequency Therapeutics lobbying by quarter
QuarterAmountReports
Q4 2022$30K1
Q1 2023$30K1
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Budget and appropriations$20K · 2 reports
  • Health issues$20K · 2 reports
  • Medical research and clinical labs$20K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports

Firms it paid

Firm
Tides Group$60K2 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
23/04/19for Q1 2023Tides Group$30K
23/01/20for Q4 2022Tides Group$30K